{
    "clinical_study": {
        "@rank": "9867", 
        "arm_group": [
            {
                "arm_group_label": "Standard of Care", 
                "arm_group_type": "No Intervention", 
                "description": "Routine implementation of the national PMTCT guidelines which are an adaptation of the WHO's \"Option A\""
            }, 
            {
                "arm_group_label": "Conditional Cash Transfer", 
                "arm_group_type": "Experimental", 
                "description": "Financial incentive to attend regular clinic visits and receive PMTCT care"
            }
        ], 
        "brief_summary": {
            "textblock": "The goals of the proposed study are to: 1) test whether small, increasing cash payments to\n      HIV-infected pregnant women, on the condition that they attend scheduled clinic visits and\n      receive proposed services, will increase the proportion of women who receive the most\n      effective antiretroviral regimen they are eligible for by the time of delivery, and 2)\n      elucidate factors that facilitate or inhibit the uptake and adherence to the PMTCT cascade,\n      and to what extent the conditional cash payment program addresses these factors.\n\n      This intervention will be implemented and evaluated within our well-established PMTCT\n      program in Kinshasa, Democratic Republic of Congo (DRC),"
        }, 
        "brief_title": "Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "HIV", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Newly diagnosed as HIV-positive\n\n          -  Pregnant between 28 and 32 weeks of gestation (>27 and  <32 completed weeks of\n             pregnancy)\n\n          -  Intend to stay in Kinshasa through delivery and six weeks postpartum\n\n          -  Able and willing to participate (provide informed consent)\n\n        Exclusion Criteria:\n\n          -  Women will be excluded from the study if they are severely ill and require extended\n             hospitalization or need to be cared for at a referral hospital out of the PMTCT\n             network"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838005", 
            "org_study_id": "12-1676", 
            "secondary_id": "1R01HD075171-01"
        }, 
        "intervention": {
            "arm_group_label": "Conditional Cash Transfer", 
            "description": "Eligible women randomized to the intervention group will receive the standard of care plus small and increasing cash payments, on the condition that they attend scheduled clinic visits on time (+/-5days), accept HIV services, deliver in a health facility, and at six weeks postpartum adhere to prescribed infant prophylactic drugs (cotrimoxazole, extended NVP) and provide blood sample for DNA PCR infant early HIV diagnosis.", 
            "intervention_name": "Conditional cash transfer", 
            "intervention_type": "Behavioral", 
            "other_name": "Contingency management"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Contingency management", 
            "conditional cash transfer", 
            "PMTCT", 
            "Retention", 
            "HIV"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "contact": {
                "email": "chalasjl@yahoo.fr", 
                "last_name": "Jean Lambert Chalachala, MD"
            }, 
            "contact_backup": {
                "email": "okitow@yahoo.fr", 
                "last_name": "Emile Okitolonda, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Kinshasa", 
                    "country": "Congo"
                }, 
                "name": "Kinshasa School of Public Health"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Congo"
        }, 
        "number_of_arms": "2", 
        "official_title": "Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services", 
        "overall_contact": {
            "email": "myotebieng@cph.osu.edu", 
            "last_name": "Marcel Yotebieng, MD, PhD", 
            "phone": "614 688 2133"
        }, 
        "overall_official": [
            {
                "affiliation": "Ohio State University", 
                "last_name": "Marcel Yotebieng, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Kinshasa School of Public Health", 
                "last_name": "Emile W Okitolonda, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board", 
                "Democratic Republic of Congo: Kinshasa School of Public Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At each monthly visit starting at randomization (28 weeks), participants will be evaluated for the following conditionalities:\nattended the scheduled visit on time (+/- 5 days)\naccept HIV status and services proposed to them\nreturn to deliver in the clinic At the end of the follow-up (6 weeks post-partum)the proportion of participants who adhered to all these conditions will be calculated for each study group", 
            "measure": "proportion of women who were adherent to all conditionalities and received the most effective ARV intervention they were eligible to receive and delivered at an affiliated maternity", 
            "safety_issue": "No", 
            "time_frame": "6 weeks postpartum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838005"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University", 
            "investigator_full_name": "Marcel Yotebieng, MD", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Proportion of HIV-exposed infant who tested positive at 6 week postpartum", 
                "measure": "Mother to child transmission rate at six weeks and HIV-free survival.", 
                "safety_issue": "No", 
                "time_frame": "6 weeks post partum"
            }, 
            {
                "description": "Proportion of children born to HIV+ enrolled mothers who are alive and non infected with HIV", 
                "measure": "HIV-free survival at 18 month.", 
                "safety_issue": "No", 
                "time_frame": "18 months porstpartum"
            }, 
            {
                "description": "Proportion of infants born to HIV-infected participants who at 6 weeks postpartum are receiving the extended nevirapine prophylaxis and have been tested for HIV", 
                "measure": "Proportion of HIV-exposed infants who at their six week visit received extended Nevirapine (NVP) had a DNA PCR test", 
                "safety_issue": "No", 
                "time_frame": "6 weeks Postpartum"
            }
        ], 
        "source": "University of North Carolina, Chapel Hill", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Kinshasa School of Public Health", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of North Carolina, Chapel Hill", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}